Theralase Technologies Inc. V.TLT

Why the FDA need TLT-Ruvidar...

[wildbird1]

All the long on this board know why, but for the new people on this board, below is a good reason to hold on to your TLT shares.

Keytruda,CG007, Immunity Bio(Anktiva N803+BCG)....
In a video by Dr.McFarland (March 2,2024), Dr.McFarland said '' The above are all continous treatments, they are not a one time treatment(unlike TLT-Ruvidar 1-2 treatments), you have to take the above treatments for as long as you can tolerate them''.

Adstiladrin.
Adstiladrin has a 23%CR at 15 months(TLT-Ruvidar 40%CR optimized).
Adstiladrin can not treat immunodeficients patients.
In this link...
https://drugs.com/drug-interactions/nadofaragene-firadenovec,adstiladrin.html
Adstiladrin has 285 major drugs interactions(that is huge).

-TLT-Ruvidar has a 40%CR at 15 months(optimized).
-TLT-Ruvidar will treat immunodeficients patients.
-TLT-Ruvidar has no major drugs interactions.
-TLT-Ruvidar is 100% safe(no restrictions).

In short TLT-Ruvidar is a 1-2 time treatment that will treat patients that nobody else can treat.

The above is why the FDA need TLT-Ruvidar, and why you should hold on to your TLT shares.

[N0taP00p]

Yes, yes.  We see this info in various forms, about 3 times a week.  Helps pass the years and years of waiting.   The pot of gold is always just ahead of us, always imminent...before it gets pushed again, buried in an unrelated NR, with nary a clarification given as to what specifically caused the push.  Wouldn't it be professional to simply tell investors which

[DeathXray33]

"Keytruda, CG007, Immunity Bio(Anktiva N803+BCG).... In a video by Dr.McFarland (March 2,2024), Dr.McFarland said '' The above are all continous treatments, they are not a one time treatment(unlike TLT-Ruvidar 1-2 treatments), you have to take the above treatments for as long as you can tolerate them''. ----------------------------- I bought more Friday & going to on